We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




iCAD to Merge with CADx and Qualia Computing

By HospiMedica staff writers
Posted on 15 Dec 2003
Print article
An agreement has been announced whereby iCAD, Inc. (Nashua, NH, USA; www.icad.med.com) will merge with privately held CADx (Beavercreek, OH, USA) and Qualia Computing, Inc. (also in Beavercreek). Currently, the companies are working on a joint and coordinated basis.

The combination of iCAD and CADx represents a merger of two growing computer-aided detection (CAD) companies with complementary strengths and minimal duplication of activities. iCAD and CADx have installed more than 300 CAD systems for the early detection of breast cancer. CADx anticipates profitable operations in the fourth quarter of 2003 and in 2004, while iCAD has projected profitable operations for 2004. To complete the merger, iCAD will issue 4.3 million shares of its common stock in exchange for all outstanding shares of Qualia Computing, Inc. and CADx System, Inc. In addition, iCAD will pay U.S.$1.55 million in cash and execute a 36-month promissory note in the amount of $4.5 million to purchase Qualia shares owned by two institutional investors. CADx will operate as an independent subsidiary of iCAD, Inc.

"The benefits of this merger for CADx and its customers include access to iCAD's new iQ technology, which allows all women's healthcare facilities, regardless of size, to offer CAD solutions to women at risk,” said Dr. Steven Rogers, president and CEO of CADx and Qualia Computing.




Related Links:
ICAD
CADx
Qualia Computing
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Examination Light
Avante Vista Flex
New
6-Channel ECG System
SE600

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.